biological resources that require minimal processing and cost significantly less. Nature, through millions of years of genetic evolution, has enabled unicellular photosynthetic algae "diatoms" to create precisely tuned nanostructured silica biomaterials with 3D porous structures. [18] Diatoms, a source of natural biosilica, can be easily cultivated to produce biosilica as desired, however, the most important source is from their fossilized mineral remains of diatoms known as diatomaceous earth (DE) silica. This DE mineral, is the sediments of accumulated dead diatoms at the bottom of oceans or lakes over millions of years, which are mined and used as low cost biosilica mineral (≈$200 per tonne) across many industries including food and beverage industry, agriculture, and natural medicine. It is amazing that porous silica nanoparticles (SiO 2 NPs) with an intricate 3D structure can be obtained from these inexpensive and abundant natural mineral deposits at a scalable, reproducible, and cost-effective manner. Due to these unique properties, DE is considered a promising candidate to a variety of applications in many fields like nanofabrication, drug delivery, biosensing, molecular separation, chromatography, energy storage, water purifications, and many more.
This review article will present the recent progress on applications of natural DE silica materials available as low cost mineral for their biomedical applications with major focus on drug delivery. The functionalization of DE silica micro-/nanoparticles, the first step in order to improve their physicochemical properties and characteristics for tunable and responsive drug release, will be also described. In addition, this article will focus on the advances of the fabrication of biodegradable porous silicon (pSi) from silica diatoms that offer improvements in their properties for development of new biodegradable natural-based micro-and nanodrug carriers. Finally, various other biomedical applications of diatoms such as tissue engineering and hemorrhage control will be discussed.
Environmental, Economical, and Industrial Values of DE Silica
Both the diatom algae and DE silica materials derived from the diatoms play an important role in our environment and industrial applications. Diatoms are a vital for global carbon assimilation (i.e., fixing inorganic carbon, in form of CO 2 , into organic carbon via photosynthesis), oxygen production, recycling silicon with significant ecological and biological impact on the life of our planet. [19] The diatoms represent an essential and key food source in food chain in oceans, which are rich in lipids, fatty acids, elements (e.g., nitrogen), carotenes, and phenolic compounds that are essential to all living species of aquatic environment. In addition to the abovementioned importance, diatom algae have been also used as source of biofuel owing to high fatty acids and oils contents. Thalassiosira weissflogii and Cyclotella cryptica were successfully cultivated under nitrogen limited environment and explored for ability of oil production and also production of pharmaceutical products. [20] Therefore, diatoms are demonstrated as potential nanofactories for biofuel production, which can be employed on large scale and it is under extensive development. [21] Upon death, diatoms sink to the bottom of ocean and these fossilized diatoms become the source of DE silica or diatomite mineral are mined for use in >300 products across many industries. For example, DE silica are used as additives in construction materials, paints (e.g., CelaBrite), abrasive polishes and tooth paste (e.g., Celatom), polymers, filtration aids, rubber industry (e.g., Celatom), water and air adsorbents, and so on. [22] Shaheer Maher is a pharmacist and also a staff member of the Faculty of Pharmacy, Assiut University, Egypt. He spent one year as a visiting researcher at the Centre for Microsystems Technology (CMST), Ghent University, Belgium working on a microfluidics project. In 2014, he joined Prof. Dusan Losic's Nano-research group at the School of Chemical Engineering, the University of Adelaide, SA, Australia. Shaheer's research interests include drug delivery, dosage forms design, nanostructured and porous materials, nanofabrication, smart bone implants, electrochemical anodization, and microfluidics.
Tushar Kumeria is currently a National Health and Medical Research Council (NHMRC)
Early Career Fellow at the School of Pharmacy, The University of Queensland(UQ), Australia. He completed his Ph.D. in 2015 from the University of Adelaide with a Doctoral Thesis Medal. In 2015, he moved to the USA for a postdoc with Prof. M. J. Sailor's group at University of California-San Diego (UCSD). Tushar joined UQ in 2017 after spending two years at UCSD and is presently involved in multidisciplinary research on nanoporous materials for application in the field of drug delivery, photonics, and optical sensing. [24] However, long-term exposure to large quantities of DE silica is not a major concern for biomedical applications this novel 3D biomaterial as they require minute quantities and short-term exposure through oral rout that has fast clearance rate. In medical device industry, DE is currently used as insulators in medical devices (e.g., autoclaves) since they do not cause lung allergy in contrast to other materials such as asbestos. [25] 3. DE Silica: Structure, Purification, and Surface Functional Properties
Dusan Losic is a professor at the School of Chemical

Unique 3D Structure of DE Silica
Diatoms are unicellular eukaryotic algae, which occupy every part of aquatic environments with significant geochemical, ecological, and biological impact on development and maintenance of the life on our planet. These organisms are recognized as microscopic nanofabrication factories that use simple self-assembly process to generate intricate 3D porous silica shell called a frustule. There are more than 100 000 different species of diatoms identified so far and each has a unique 3D frustule shape (e.g., drum-like, triangular-box, circular-box, and many more), sizes (from 500 nm to 50 µm), surface features such as pores, ridges, and spines with specific functions and properties (Figure 1) . [17] Despite difference in shape, there are common features among frustules of all the diatom species like their hollow pill-box structure made of two overlapping valves sealed together by girdle bands. Primarily, the diatom cell encases in this porous shell for physical protection, however, morphological features of the diatom frustules have multifunctional properties that enable to provide molecular sorting of nutrients, antibacterial protection, the optimized energy and light harvesting functions, and the movement that made them one of the most successful living species. Amazingly, these unicellular diatom algae create a 3D structure of the frustules composed of linked silica nanoparticles with very high reproducibility and precision of tens of nanometers that are genetically controlled and developed through millions of years of evolution process. Schematic representation of typical wall structure of diatom frustules is shown in Figure 2 , presenting the structure of Coscinodiscus sp diatoms species, and the valves of frustule consists
Adv. Healthcare Mater. 2018, 7, 1800552 Figure 1 . Different shapes and structures of diatoms. a-i) Scanning electron microscopy (SEM) images of several marine diatom species. Scale bar = 10 µm. Reproduced with permission. [17] Copyright 2009, Wiley-VCH.
www.advancedsciencenews.com www.advhealthmat.de of stacked hexagonal chambers separated by silica plates in three integrated porous layers. The porous plates have uniform pores decreasing or increasing in diameter from the outside to the inside. Their morphology is organized to provide both mechanical protection, molecular and colloidal sorting of nutrients. The outer surface plate has the finest pores, 40 nm in diameter. This plate is termed the cribellum. The plate separating the two layers of chambers contains pores of intermediate diameter, 120 nm, and is termed the cribrum. The cribrum and cribellum are also referred to as sieve plates, with reference to their presumed function. The innermost pores sitting against the sieve plate surface are 1100 nm in diameter and are referred to as the foramen. [26] The large species-specific variation in shape, size, geometry, organization, and density of pore structures represent subtle changes in the material structure to optimize movement and interactions in complex biological environment. Diatom frustules possess many unique mechanical, structural, optical, photonics properties, excellent biocompatibility, high surface area with micro-and nanoscale porosity that made them very attractive material for broad applications. Diatom frustules also inspired the design and production of novel nanostructured materials due to their unique 3D porous pill-box biologically derived structures, which could be suitable for movement in biological environment. Their hollow porous microcapsule structure render them ideal for the development of nano-/ microdrug carriers for a variety of medical therapies including theranostics and microrobotics. [27, 28] The hollow and porous structure of DE silica offers large surface area that enables high loading capacity and the porous structure maintains the therapeutic drug in amorphous form that is crucial for enhancing the solubility and increasing the permeability of lipophilic drugs, as reported in a number of studies from our group and others. [29] [30] [31] [32] 
Purification of Raw DE Silica
The raw DE is supplied as rocks or powder form by the DE mining companies and mineral processing industry and available worldwide in large quantities (500.000 per year). However, these raw DE minerals have impurities (alkaline earth, alkaline metals, iron, and organic materials) that may interfere with the properties of DE necessary for some particular applications. Therefore, it is important that the mined raw DE mineral is processed to remove these impurities and purify the DE into material with the quality required for these applications. The industrial DE processing of the raw DE usually includes crushing, purification, and size-based separation. [33] The crushing is usually done by a milling equipment to obtain a fine-powdered DE with particle size of sub-micrometer to several micrometers, which results in a mixture of full DE frustules and broken fragments. The purification steps to remove the undesired chemical impurities involve both physical and chemical purification methods to obtain pure DE material without any traces of organic and inorganic impurities. Physical purification process relies on burning the impurities, and thus involves calcination of the raw DE at high temperatures (i.e., >600 °C). Although very simple and effective, calcination of raw DE leads to sintering of the DE frustules and making crystalline silica that possess toxicity and it is undesirable for commercial applications. [34] Thus, chemical methods, generally relying on acid treatment of a raw DE in a hot medium are preferred. [35] It is worth mentioning that the acid leaching treatment times are strongly dependent on the source of raw DE (i.e., impurities). In this field, major contributions have come from Goren et al., who explored the use of hydrochloric acid as the leaching agent and studied the HCl concentration, incubation time, incubation time, and concentration of DE in the leaching medium. [35] [36] [37] For biomedical and some other applications, it is critical to retain and obtain intake diatom microcapsule structures from raw materials that is challenging and requires delicate the size-dependent separation process to remove fractured diatom parts. Our team refined this process to obtain pure diatom microcapsules from raw DE rocks using combination of sedimentation and filtration process. [30, 38] 
Surface Modification of DE Silica
Inherently, the surface of purified DE, due to silicon dioxide building blocks, offers the potential to tailor the surface properties of the DE for development of new class of bioengineered materials for biomedical applications. Silica contains hydroxyl (OH) groups on the surface that can be readily used Figure 2 . a) Schematic illustration of a centric diatom frustule with cross-sectional profile of the silica wall, which typically consists of three overlapping porous layers. b) SEM image of a C. sp frustule with images of pore structures on these layers. Reproduced with permission. [26] Copyright 2007, SpringerLink.
www.advancedsciencenews.com www.advhealthmat.de to functionalize DE surface using well-established chemical modification strategies. The surface modification of diatom structures has been progressed in the last decade using many different approaches mainly based on strategies developed for synthetic silica particles that include application of organic monolayers, polymers, proteins, and coating with metal and inorganic oxide layers. [39] Most common methods are based on using reactive silanol (SiOH) groups available on diatom surface which can be easily functionalized with many reactive species (e.g., NH 2 , COOH, SH, and CHO), providing robust coupling points for the immobilization of biological or chemical moieties such as drugs, enzymes, proteins, antibodies, aptamers, DNA, sensing probes, etc. [40, 41] It is worth mentioning that silanization is widely employed via the formation of SiOSi covalent bonds for stable attachment of different active moieties on diatoms surface. [29, 42] Figure 3 shows schematic illustration of typical surface functionalization of diatom microcapsules using organosilanes via the formation of self-assembled layer, through SiOSi covalent bonds. [43] Modification of surface with desired chemical terminal group enables immobilization of variety of biomolecules like antibodies, nucleotides, etc., and enhanced drug loading for applications in drug delivery and biosensing. Two approaches are widely adopted for immobilization of active biomolecules onto the surface of chemically modified DE: noncovalent interactions involving physical adsorption and other weak interactions, and covalent immobilization involving strong covalent binding. The major problems of the noncovalent binding (e.g., electrostatic interaction) is that the strength of the bond depends on solution condition, such as pH or changes in ionic strength, thus lowering stability. Hence, in terms of stability and reproducibility, the covalent binding of biomolecules to the surface of diatoms is often used for reallife applications. [42] 4. Natural DE Silica Microcapsules for Therapeutics Delivery
DE Silica-Based Drug Delivery Systems
The major challenge for drug/pharmaceutical industry is to deliver therapeutic agents at effective concentration to specific areas in the human body (i.e., diseased tissues) with minimal side effects on healthy tissues. [44, 45] In addition, over 70% of new drug targets and many existing drug molecules belong to the Biopharmaceutics Classification System (BCS) Class II or IV that show poor physiochemical properties such as low solubility under physiological environment, insufficient cellular uptake, limiting their biodistribution and efficacy. In last few decades, a variety of advanced drug carriers have been developed to protect them from degradation/ rapid clearance, enhance their physicochemical properties, and increase their cellular uptake. These advanced drug carrier systems have been proven to improve the drug distribution and enhance the therapeutic efficacy in targeted tissues with minimal adverse effects. [46] [47] [48] As mentioned above, synthetic porous silica (macro-, meso-, or microporous) has been extensively studied as drug carrier owing to its unique physicochemical properties. [49] [50] [51] However, its advantages are challenged by expensive and time consuming manufacturing procedures, which also involve the use of toxic solvents that may leave residue in the final products. [17, 52] Biosilica, naturally synthesized by unicellular algae diatoms is a potential candidate as advanced drug carrier system to realize safe and more effective therapeutics in the future. [53] The idea of exploiting the biological structure of diatom to construct new materials was first mentioned by Morse in 1999, where he proposed that the biologically produced silica of diatoms exhibited a genetically controlled precision of nanoscale architecture that exceeded the current capabilities of human engineering. [54] Utilizing diatoms purposefully as a delivery . Reproduced with permission. [43] Copyright 2016, SpringerLink. b) Schematic illustration of diatom functionalization using organosilanes and phosphonic acids with hydrophobic and hydrophilic properties.
www.advancedsciencenews.com www.advhealthmat.de system was experimentally demonstrated by Rosi et al. in 2004, when they controlled the loading and release of gold nanoparticles from the surface of DNA-functionalized diatom surfaces. [55] The first use of DE silica microcapsules for encapsulation of therapeutic drugs for oral delivery was first explored by our group, Aw et al. using in vitro testing. [38, 56] Results confirmed the efficacy of diatoms for drug delivery of the water insoluble drug, indomethacin, with about 22 wt% drug loading capacity and a sustained drug release over 14 days. Notably, two phases of drug release from the diatom microcapsules were observed: the first one was burst release over 6 h due to the detachment of drug adsorbed on the surface. The second phase was slow, and a prolonged release was obtained over 2 weeks with zero order kinetics ascribed to the release from the interior of the diatoms pores. In the same context, Zhang et al. evaluated the oral delivery of prednisone and mesalamine loaded onto silica diatoms. Results confirmed sustained release of both drugs. At the same time, in vitro toxicity assessment showed neglected toxicity of diatoms frustules at concentrations up to 1000 µg mL −1 , even on the Caco-2/HT-29-cocultured monolayer ( Figure 4) . Moreover, the permeation of both the drugs was enhanced when tested using Caco-2/HT-29-cocultured monolayers. [32] The presence of surface hydroxyl groups on DE silica opens new possibilities for improving their surface properties to provide a better control over the drug loading and release profiles. The impact of surface functionalization on diatom silica microcapsules on drug loading and release of water insoluble drug, indomethacin was then explored by Aw et al. to adopt surface modifications as strategy for controlling drug release. [29] In this study, two different modifications were tested using organosilane 3-aminopropyltriethoxysilane (APTES) and N- (3-(trimethoxysilyl) propyl) ethylene diamine (AEAPTMS), and phosphonic acids (2-carboxyethyl-phosphonic acid and 16-phosphono-hexadecanoic acid) to impart hydrophilic and hydrophobic properties to the microcapsules (Figure 3b) . Results showed that an appropriate surface diatoms functionalization can tune drug loading (15-24 wt%) and drug release (6-15 days) from slow to sustained release for more than 2 weeks. Notably, the hydrophilic functionalization increased the drug loading and prolonged the drug release. Contrarily, the hydrophobic modification caused a lower drug loading and faster drug release. Similarly, Bariana et al. [30] employed methoxy-poly-(ethylene-glycol)-silane (mPEG-silane), 7-octadecyltrichlorosilane (OTS), 3-(glycidyloxypropyl)trimethoxysilane (GPTMS), and two phosphonic acids, namely 2-carboxyethyl-phosphonic acid (2 CEPA) and 16-phosphono-hexadecanoic acid (16 PHA) to control drug loading and release characteristics of water insoluble drug (indomethacin) and water soluble drug (gentamicin). Successful grafting of these functional groups with different interfacial properties was confirmed with Fourrier transform infra-red spectroscopy (FTIR) analysis and leads to differences in drug loading capacity (14-24 wt%) and release time (13-26 days) depending on functional groups on the surface of diatom microparticles. Results showed that hydrophilic surfaces, due to the presence of polar carboxyl, amine, or hydrolyzed epoxy group, favor extended release of indomethacin, while the hydrophobic diatom surface modified with long chain hydrocarbons gives a prolonged sustained release profile for gentamicin. [30, 31] Surface functionalization also enables modification of DE silica with other biological or synthetics materials to impart (n = 3). An unpaired Student's t-test was employed and the level of significance was set at probabilities of *p < 0.05, **p < 0.01, and ***p < 0.001. d) Transmission electron microscopy image of Caco-2/HT-29 coculture monolayer after incubating with 1000 µg mL −1 diatoms for 3 h. The tight junction (arrow) and microvilli (dashed arrow) clearly show the functionality of the coculture monolayer. Reproduced with permission. [32] Copyright 2013, Elsevier. secondary properties like magnetic actuation, triggered drug release, and so on. In this regard, our group, Losic et al. fabricated magnetically guided drug microcarriers through surface functionalization of diatoms with dopamine modified iron oxide nanoparticles. They demonstrated the possibility to obtain a sustained release for a period of 2 weeks of poorly water soluble drug (indomethacin) from such magnetized diatoms. [42] This concept potentially can be used as magnetically guided targeted drug delivery of cancer drugs, providing many advantages compared with conventional DD systems.
Another improvement of DE silica drug carriers was demonstrated by Kumeria et al. to control the release of their drug cargo. A hybrid diatom microcapsule whose surface was decorated with 2D material graphene oxide (GO) nanosheets was fabricated, for the first time, to impart the system with a pHdependent triggered release capabilities. To achieve this, the surface of DE silica structures was silanized using APTES to obtain positively charged amine functional groups on the surface (Figure 5) , to attach GO nanosheets either electrostatically or covalently to the DE surface. Results showed that the release of a nonsteroidal anti-inflammatory drug such as indomethacin under different pH conditions can be significantly altered by this approach. [57] The release behavior was governed by changes in the chemical interaction of the loaded drug with the graphene oxide in different pH buffers. In other attempts to control drug release from diatoms surface, Vasani et al. prepared a delivery system based on DE silica, which relies on a polymer acting as a physical actuator to control the release of drugs rather than chemical interactions. [58] They employed surface-initiated atom transfer radical polymerization (ATRP) to graft thermoresponsive copoly mers of oligo(ethylene glycol) methacrylates (O(EG)MA) onto the surface of diatoms microcapsules to demonstrate the application of the resulting composites for thermoresponsive drug delivery. Drug release of antibacterial agent, levofloxacin from the copolymer modified microcapsules showed strong temperature dependence when comparing release kinetics below and above the lower critical solution temperature (LCST) of the grafted copolymer, Figure 6 . [58] In addition to chemical functionalization of diatoms silica surface to achieve stable and high drug loading, Santos and coworkers highlighted the benefits of incorporation polymers and peptides/proteins to enhance biocompatibility, reduce aggregation, enhance cellular internalization, and improve aqueous stability. [59] Terracciano et al. coated DE silica frustule fragments as nanoparticles (DNPs) with polyethylene glycol (PEG) and cell-penetrating peptide (CPP) for delivery of anticancer drug, sorafenib. [59] DNPs were obtained through mechanical crushing followed by sonication of micrometer-sized diatoms frustules. After that, surface functionalization was carried out with APTES followed by attachment of PEG through formation of amide bond between amino groups (NH 2 ) of APTES on diatoms surface and the carboxylic groups (COOH) of PEG by 1-ethyl-3-[3-dimethylaminopropyl]carbodiimidehydrochloride/-N-hydroxysuccinimide (EDC/NHS). Finally, CPP was attached to the surface of the PEGylated diatoms nanoparticles, as shown in Figure 7 . The prepared nanoparticles were confirmed to be stable in aqueous solution and biocompatible when tested with red blood cells (RBCs) and breast cancer cells (MCF-7 and MDA-MB-231). At the same time, the incorporation of CPP significantly improved cellular uptake. In addition, coating with PEG leads to twofold increase in the amount of anticancer drug loading compared to uncoated DNP.
Targeted drug delivery was also investigated using diatoms silica shells. In this context, magnetically active frustules, loaded with curcumin, were prepared by Javalkote et al. and then investigated for their chemotherapeutic activity. The study suggested that the prepared curcumin-loaded microshells could be applied as a potential carrier to deliver cargo for efficient chemotherapy. [60] In a similar study, in vivo administration of diatoms with iron oxide nanoparticles (IONPs) as magnetic delivery carriers was demonstrated by Todd et al. [61] Significant particles accumulation (6.4 times higher) at the tumor site was observed when a magnetic field was applied compared to control.
Recently, diatom silica structures were explored for gene therapy applications. Gene therapy is emerging as new strategy for treatment and cure for many diseases that are impossible to treat with conventional therapy and remove the root cause
Adv. Healthcare Mater. 2018, 7, 1800552 Figure 5 . a) Schematic representation of covalent functionalization of diatoms frustule surface. SEM images of the graphene oxide diatom nanohybrid prepared through electrostatic attachment, showing b) a full diatom structure with attached GO partially covering the pores, c) high magnification image of the diatom pores covered by larger GO sheets, and d) a high magnification image of diatom silica covered with smaller GO nanosheets. Reproduced with permission. [57] Copyright 2013, the Royal Society of Chemistry.
www.advancedsciencenews.com www.advhealthmat.de of the diseases. Therefore, delivery of small interfering RNA (siRNA) has been established as an effective strategy for cancer treatment. siRNA could be employed to inhibit expression of defective genes (gene silencing) selectively in cancer cells. Such defective genes are mainly responsible for the propagation or uncontrolled growth of cancer cells, thus gene silencing could result in cancer cell death. However, siRNA molecules are subjected to degradation by nucleases before reaching their site of action (i.e., cancer cells). As a result, they should be loaded onto a carrier that is capable of protecting them till they reach their targets. Several nanocarriers were developed for this purpose such as liposomes, polymeric nanoparticles, etc. [62, 63] The first attempt to use diatoms for siRNA delivery involved linking poly-d-arginine peptide/siRNA complex covalently to APTES surface-modified diatom. [64] In this study, drug free DE silica nanoparticles showed very low toxicity after incubation for 72 h with human epidermoid cancer cells (H1355). At the same time, effective delivery of siRNA into cytoplasm with effective gene silencing activity was also demonstrated, Figure 8 . Diatoms are recognized as nature biofactories that produce DE silica from silicic acid from water using genetically controlled self-assembly system which is possible to be modified to further tune the properties of the silica shell they produce. This concept is successfully demonstrated with several groups showing the regulation of gene expression (e.g., gene silencing/overexpression) in diatoms in order to generate [59] Copyright 2015, the Royal Society of Chemistry.
www.advancedsciencenews.com www.advhealthmat.de diatoms species with unique properties. [65, 66] For example, Delalat et al. developed genetically engineered biosilica diatoms frustules displaying Immunoglobulin G (IgG)-binding domain of protein G (GB1-bioselica) on their surface to deliver water insoluble cytotoxic agents. [52] The aim of this study was to generate silica diatoms with simultaneous attachment of antibodies, to target tumor cells together with hydrophobic chemotherapeutic agent without utilizing any organic solvents or covalent cross-linking. Two chemotherapeutic agents were used, camptothecin (CPT) and its more potent derivative 7-ethyl-10-hydroxy camptothecin (SN38). They were first formulated as N-[1-(2,3-dioleoyloxy)propyl]-N,N,N-trimethylammonium (DOTAP) liposomes containing CPT and cetrimonium bromide (CTAB) micelles containing SN38. To specifically target cancer cells, IgG antibodies (e.g., antibody specific for the p75 neurotrophin receptor (p75NTR) (anti-p75NTR)) were attached to GB1-bioselica to form antip75NTR-GB1-bioselica. After that, the chemotherapeutic agents were loaded onto anti-p75NTR-GB1-bioselica through electrostatic interaction. As a result, these genetically engineered biosilica nanoparticles were capable to specifically target neuroblastoma and B-lymphoma cells. When administered into SH-SY5Y neuroblastoma tumor-bearing BALB/c nude mice, SN38-loaded antip75NTR-GB1-bioselica nano particles caused significant reduction in tumor growth, as shown in Figure 9 . These studies showed a great potential to genetically manipulate properties of cultured diatom silica and use them as a DDS for specific medical therapies.
Biodegradable 3D Drug Carrier Based on DE Silica
All these recent and previous studies have shown the ability of silica diatoms frustules to perform sustained and controlled release of a broad range of therapeutic agents and have potential to be clinically used. One of the key prerequisite for a drug carrier systems is that the carrier should degrade/dissolve into nontoxic components that can be easily cleared by the body. However, the building units of diatoms frustules are made of silica that has a poor biodegradability in biological fluids. [67] [68] [69] [70] [71] [72] This leads to the accumulation of the silica particles, especially in case of repeated administration in organs, which has limited blood supply (e.g., vitreous body). In addition, significant quantities of systemically administered targeted drug delivery systems are cleared by the phagocytic system before reaching their targets, increasing the likelihood of unintended acute or chronic toxicity. [73] In one study, Borak et al. studied the biodistribution of silica particles in rats. Results revealed that silica particles were mainly trapped inside the lungs air sacs and kidney glomerulus. [74] To overcome the limitations of silica materials as drug carriers, synthetic pSi was recognized as an attractive alternative. [75] However, it worth mentioning that pSi suffers from major limitations related to its fabrication process which is based on electrochemical etching of silicon wafers which a time consuming synthesis procedure involving several steps. [75] The scalability of this fabrication process is challenging due to the high costs associated with this process, including silicon wafers, chemicals, associated equipment (e.g., etching cells, power supplies, safety equipment, etc.). Third, using highly toxic chemicals, such as hydrofluoric acid (HF), requires specific safety precautions during handling. [75] Moreover, the use of HF during the synthesis process of pSi may eventually lead to residual toxicity in pSi microparticles, limiting the applicability of this system for real biomedical applications. [76, 77] A study by Koynov et al. proved the presence of residual toxic silicon tetrafluoride (SiF 4 ) and fluosilicic acid (H 2 SiF 6 ), which are formed during fabrication of pSi particles using the commonly used etching technique. These toxic residues usually get entrapped within the mesoporous structure of pSi. The pSi toxicity study explored using AY-27 rat bladder cancer cells showed a significant viability reduction upon application of pSi nanoparticles. [78] Similar results were found by Liu et al. when they studied the effect of pSi on colorectal cancer cells (HT-29). [79] Adv. Healthcare Mater. 2018, 7, 1800552 Figure 8 . Confocal microscopy on cells treated with siRNA-modified diatomite nanovectors (first line) and untreated cells as control (second line). Cell nuclei and membranes were stained with Hoechst 33342 and WGA-Alexa Fluor 488, respectively. siRNA was labeled with Dy547. Scale bar corresponds to 20 µm. Reproduced with permission. [64] Copyright 2015, Elsevier.
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Thus, converting silica DE into a biodegradable form, like silicon DE replicas, is recognized as new source of low cost and less toxic source of Si drug carrier materials that will overcome the issues related to both the silica and synthetic pSi nanoparticles. This assumption is based on the fact that silicon is a common trace element found in the human body (around 5 ppm in human plasma) and its degradation product, silicic acid (H 4 SiO 4 ), is the form predominantly absorbed by humans and is naturally found in numerous tissues. [80] Furthermore, previous studies confirmed that upon administration of silicic acid to humans, it would be efficiently excreted from the body by the kidney. [81, 82] Therefore, it is believed that silicon replicates of DE silica can overcome the intrinsic limitations of synthetic pSi produced by electrochemical etching of silicon. The silicon replicates of DE silica are industrially scalable, cost-competitive, and time-effective fabrication process without the use of hazardous chemicals. Furthermore, these replicates are fully degradable and noncytotoxic for biomedical application, while having photoluminescence properties. [28, 83] Recently, in one cutting edge study, Bao et al. converted silica diatoms frustules, to pure silicon diatoms frustules replicas by applying a magnesiothermic reduction reaction to be used as gas sensors. [84, 85] Such Mg catalyst-based reduction process not only makes it possible to achieve a complete conversion of silica diatoms frustules into silicon diatom replicas, but also to preserve the structure and morphology of diatom frustules. This opened the door to obtain silicon particles from these naturally occurring diatom frustules for advanced drug carrier applications. The first development of a new type of self-reporting drug nanocarriers based on biodegradable and luminescent porous silicon derived from naturally Adv. Healthcare Mater. 2018, 7, 1800552 Figure 9 . Antibody-labeled diatom biosilica loaded with SN38 reduces neuroblastoma SH-SY5Y tumor growth and histochemical analysis of SH-SY5Y xenografts. a) Average tumor volumes measured over 17 days in immunodeficient Balb/c nude mice that were implanted with SH-SY5Y neuroblastoma cells and treated with single dose of different diatom biosilica-based materials: GB1-biosilica (n¼4, black squares), anti-p75NTR-GB1-biosilica (n¼4, blue triangles), anti-p75NTR-GB1-biosilica-SN38 (n¼4, green diamonds), and SN38-CTAB micelles alone (n¼4, red triangles). b) Comparison of average tumor volumes after 17 days of treatment with anti-p75NTR-GB1-SN38 (green), GB1-biosilica (black), SN38-CTAB micelles (red), and antip75NTR-GB1-biosilica (blue). Arrow indicates day on which the intraperitoneal injection was administered. All data are presented as mean ± standard error of the mean (S.E.M.). Statistics by analysis of variance (a) and Student's t-test (b). Letters that are not shared are significantly different ((a): P¼0.002; (b): P¼0.004). Frozen sections from individual tumors (28 days after tumor cell inoculation) from the following treatment groups (n¼4) were stained with hematoxylin and eosin (H&E). c) Untreated tumor control. Tumor treated with d) GB1-biosilica, e) anti-p75NTR-GB1-labeled biosilica, f) anti-p75NTR-GB1-biosilica-SN38-CTAB micelles, and g) SN38-CTAB micelles. Treatments via intraperitoneal injection occurred 12 days after tumor cell inoculation. Images are representative of tissue sections selected from four independent experiments (three images for each sample). Insets: dark spots show the diatom biosilica. Scale bar, 50 mm. Reproduced with permission. [52] Copyright 2015, Springer Nature.
www.advancedsciencenews.com www.advhealthmat.de occurring diatoms silica with 3D biological morphology was demonstrated by our group by Maher et al., [28, 83] Figure 10a -c. In this study, for the first time, they discovered the photoluminescence (PL) properties of the DE silicon replicates and developed an innovative self-reporting system (i.e., the drug carrier itself reports the amount of drug left or released at a time point) that took advantage of the biodegradability of the silicon under physiological environment. The biocompatibility, self-reporting the drug release capabilities of the fabricated DE silicon replicates were successfully demonstrated. Results showed that silicon microparticles from diatoms exhibited significantly high surface area compared to pristine diatoms. This was elucidated by volume reduction of the silica nanoparticle building blocks of silica shell during the reduction process of SiO 2 to Si. Furthermore, the silicon replicas exhibited high crystallinity and improved in vitro degradation rate (Figure 10d-i) when tested under physiologic conditions (i.e., 37 °C and pH 7.4). In addition, silicon particles showed pH-dependent Figure 10 . SEM, energy dispersive X-ray spectroscopy (EDAX), and X-ray diffraction spectrometry (XRD) characterizations showing magnesiothermic reduction process and conversion of a-c) diatom silica, to d-f) DE silicon replicas with no changes in morphology. g,h) SEM images showing in vitro degradation of both silica diatoms and silicon diatom replicas at 10 and 30 days in PBS pH 7.4 with i) in vitro time-resolved degradation of Silicon DE measured using ICP-OES. Reproduced with permission. [28] Copyright 2015, Wiley-VCH.
www.advancedsciencenews.com www.advhealthmat.de degradation behavior in which degradation was hampered at acidic pH medium, while accelerated at physiologic pH 7.4. The in vitro release study of daunorubicin (DNR)-loaded silicon diatom frustules for the prevention of proliferative vitreoretinopathy (PVR) showed a sustained drug release for up to 30 days. In addition, silicon replicas could act as self-reporting carriers for monitoring the release of luminescent and nonluminescent drugs by simple PL-based analysis, Figure 11 . [28] Apart from imaging and self-reporting application, reports showed that upon administration of porous silicon nanoparticles into the body, these nanocarriers accumulate at the tumor site rather than at normal tissues or organs through enhanced permeation and retention (EPR) effect, a process linked to the leaky vasculature and poor lymphatic drainage present in solid tumors. [86, 87] Nevertheless, it is worthwhile noting that the rationale behind using drug-loaded synthetic pSi nanocarriers is to reduce the side effects and toxicity associated with different therapeutics, making their release sustained over time after administration. For example, the application of the anticancer drug, DOX is limited by its narrow therapeutic index and its side effects, including bone marrow suppression and cardiotoxicity. [88, 89] Previous studies confirmed that such undesirable effects could be significantly reduced by localized DOX release at the tumor site while reducing its indiscriminate release over healthy tissues. This can be achieved by loading DOX on drug carriers that enhance its uptake and extend its release into the tumor cells. [90, 91] In that sense, our group have proposed a new concept of DE from the mine to cancer therapy whereby natural and biodegradable silicon DE nanoparticles (SiNPs) derived from diatoms silica are used for sustained delivery of DOX. [83] The concept is presented in Figure 12 .
Results demonstrated the successful production of nanosized porous silicon particles derived from silica DE microstructures by a combination of magnesiothermic reduction, milling, and ultrasonic crashing. The in vitro study of doxorubicin loaded into SiNPs showed a prolonged and sustained release for up to 30 days that confirms their capability to be utilized as drug delivery carriers for localized cancer therapy. The release showed pH-dependent effect where more drug was released in acidic environment (pH 5.5) as compared with physiologic pH (7.4). The release mechanism was found to be dependent on the convective-flow diffusion of drug molecules from the high surface area DE silica from the external and internal surface of DE silica. It is worth mentioning that intraparticle interaction-based diffusion is not feasible due to relatively large pore diameter (i.e., hundreds of nanometers). Also, the degradation of the silicon structure played a key role in the release of loaded drug, which was demonstrated by strong correlation between degradation and release. Furthermore, this study demonstrated, for the first time that SiNPs do not induce cell cytotoxicity by measuring in vitro cell viability at up to 250 µg mL −1 doses of SiNPs in two cell lines (TXSA and RAW264.7). Moreover, in vitro cell culture study showcased the www.advancedsciencenews.com www.advhealthmat.de enhanced cytotoxic effect of DOX-SiNPs as compared with corresponding concentration of free DOX. These results confirm that silicon diatom-based carriers can be obtained from inexpensive and available natural resources using scalable conversion process, and presents a promising alternative to existing synthetic silicon materials for designing advanced micro-/ nanocarriers for a broad range of biomedical applications. Most recently, our group prepared multifunctional multimaterial composite microspheres that combine diatom silicon NPs and magnetic bacterial nanowires (BacNWs) to target colorectal cancer using microfluidics technology, Figure 13a -c. [92] The spheres with drug-loaded SiNPs and magnetic nanowires were composed using microfluidic process and encapsulated in pH sensitive polymeric matrix. In this composite system, each component had an assigned task; Si DE enables controlled release of 5-flourouracil (5FU) at the cancer site, the iron oxide nanowires release curcumin (CUR) and provide a magnetic field-assisted targeting and retention of the system in the gut, and enteric polymer prevents premature release of DOX in the stomach . Results revealed the ability to guide the system to the target organ under the influence of external magnetic field and to selectively rupture the polymer shell at desired pH (Figure 13e) . A strong synergistic anticancer activity between 5FU and CUR was observed when tested in vitro using colon cancer cells SW480, showing considerable potential of these hybrids for targeting and localized therapy for colorectal cancer.
Other Biomedical Applications of DE Silica
Tissue Engineering with DE Silica
Silicon plays an important role in bone formation and maintenance, improving osteoblast cell functioning and inducing mineralization. Bone deformation and long bone abnormalities have often been associated with silica/silicon deficiency. [93] Diatomite, a natural deposit of diatom skeleton, is a cheap and abundant source of biogenic silica that can be used as regenerative medicine applications.
Adv. Healthcare Mater. 2018, 7, 1800552 Figure 12 . The concept from the mine to cancer therapy: natural and biodegradable theranostic silicon nanocarriers from diatoms for sustained delivery of chemotherapeutics. a) The stock of diatomaceous earth (DE) rocks material at the mine, b) SEM images of typical diatom silica structures obtained from DE rocks, c) diatom silica particles after fracturing diatoms by ball milling, d) converted silica structure into silicon by gas/silica displacement method based on magnesiothermic reduction process using Mg. e) Further size reduction of SiNPs by sonication process for 6 h followed by loading of anticancer drug, doxorubicin (DOX) and f) the drug release from SiNPs outside and inside cancer cell causing the cell's death (scale bars (a) = 5 µm, (c, d) = 1 µm, and (e) = 2 µm). Reproduced with permission. [83] Copyright 2016, Wiley-VCH.
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T. weissflogii silica shells were employed to enhance adhesion and proliferation of L murine fibroblasts and human osteosarcoma cell line MG63. [94] Two agents were attached to the silica surface of diatoms prior to cells growth. The first agent was the antibiotic ciprofloxacin which is commonly used to treat bacterial infections associated with bone or dental implants, while the second one was antioxidant, cyclic nitroxide 2,6,6-tetramethylpiperidine-N-oxyl (TEMPO), for scavenging reactive oxygen species to avoid any inflammation. The attachment was achieved by APTES for TEMPO and physical adsorption for ciprofloxacin. Cells were cultured on glass substrates coated with either pure diatoms frustules (F) or functionalized frustules (FTs) and compared with uncoated glass substrates as control. In order to assess cell viability and development, MTT Adv. Healthcare Mater. 2018, 7, 1800552 Figure 13 . SEM images showing a) 5FU monodisperse polymer microspheres as prepared and b) single microsphere encapsulated with 5FU-loaded diatom SiNPs and BacNWs. c) Schematic illustration of the microfluidic system for monodisperse droplet preparation of pH-sensitive microspheres with SiNPs and BacNWs containing anticancer drug (5 fluorouracil or curcumin) and proposed application for intestinal combination therapy of colorectal cancer. d) Typical pH-dependent drug release of 5FU-loaded microspheres with diatom SiNPs tested at different pH conditions and e) the viability of VSW480 cells after exposure to either single (i.e., only one type of microspheres used containing either 5FU or CUR) or multiple drug-loaded microspheres with SiNPs (i.e., both 5FU-microspheres and CUR microspheres were added simultaneously). Error bars represent S.D. (n = 3). Statistical analysis was calculated by analysis of variance (ANOVA), followed by a Bonferroni's multiple comparison test. The level of significance was set at a p value < 0.05 for * in comparison to control group (n ≥ 3 ± S.D.). Reproduced from. [92] Copyright 2017, the Royal Society of Chemistry.
www.advancedsciencenews.com www.advhealthmat.de assay and scanning electron microscopy (SEM) were used. Results showed significant increase in cell viability for both cell types after being cultured for 48 h and 7 days on either pure or functionalized frustules as compare to the control, Figure 14 .
Hemorrhage Control Using DE Silica
Uncontrolled hemorrhage can result in hypovolemic shock, which if not treated fast by fluid replacement and bleeding cessation, could cause death. Current hemostatic agents, including QuikClot zeolite and HemCon chitosan bandage, suffer from various limitations. For example, QuikClot zeolite could result in tissue burning due to high heat generation (temperatures could reach to 95 °C). Silica diatoms have been introduced as a noncytotoxic, nonimmunogenic, and inexpensive hemostatic agent that is capable to overcome the drawbacks of commonly used agents. [95] Silica diatoms offer high plasma absorptivity without any heat generation (i.e., on contrary to Zeolite). Two types of purified diatoms frustules, diatomite (commercially purchased) and diatoms (cultured in lab) were coated with chitosan with different concentrations (0.5%, 1%, 3%, and 5%) and then in vitro hemolysis and in vivo blood clotting activity tests were performed. Results showed that chitosan coating leads to negligible hemolytic activity compared to uncoated diatoms. On the other hand, the shortest clotting time was achieved when chitosan-coated diatoms (98.34 ± 26.54 s) were tested for their ability to stop bleeding after rat-tail amputation in comparison to gauze (510.26 ± 63.22 s) and commercial QuikClot zeolite (133.66 ± 21.84 s). Observation of rat tail also showed that chitosan-coated diatoms (CS-diatoms) did not result in big clot, in contrast to gauze and QuikClot zeolite, as seen in Figure 15 . This was attributed to the fast and enhanced fluid adsorption properties of CS-diatom combination compared to gauze and commercial QuikClot zeolite.
Biomedical Applications of DE Silica Based on Their Photonic Properties
Optical and photonic properties of DE silica for life biosensing are well known and often diatoms are referred to as the "living opals" or the "jewels of the sea." Since the primary component of the DE is silica, which is also the main component of glass, www.advancedsciencenews.com www.advhealthmat.de it was called diatoms as cells that live in a glasshouse. [96] Nanostructured 3D structure of DE silica interacts with light strongly to produce intense scattering that results in discrete photonic signatures discovered by Fuhrmann et al. [97] The photonic properties of DE silica are found by several groups to be highly dependent on the diatom species with many characteristic features in terms of unique light guiding, transmission, and diffraction that offer an exciting opportunity for development of optical and sensing devices. [98] Their numerical simulations proved that this effect is wavelength-dependent and does not occur at UV spectral range. Noyes et al. reported the first study of understanding interaction of light with the ultrastructure of a centric diatom species, Coscinodiscus wailesii showing the light interacts with both the valves and whole bivalves of the diatom C. wailesii with a sixfold symmetric diffraction through the valve in transmission. [99] This effect was found to be strongly wavelength-dependent with red spectral region diffracting the most (≈80%), followed by the green (≈30%) and blue spectral regions (≈20%). Their results offer an insight into the role of periodic nanostructure in the survival and growth of diatoms under a variety of conditions. An earlier study by Furukawa et al. hypothesized that the chloroplast in the diatom moved based on the intensity of light to capture and convert into energy. [100] Di Caprio et al. used digital holography to investigate the role of DE shell and its photonic properties in aiding migration of chloroplast in diatoms, C. wailesii. [101] Their results proved that photonic properties of the silica shell enable maximizing the light harvesting through migration of chloroplast in the diatoms. They utilized the inherent photoluminescence of the silica shell and the autofluorescence of the chloroplasts to confirm the plastid migration (Figure 16 ). These unique optical properties not only aid the diatom in survival, but can also be used for practical applications, mainly sensing. [102, 103] In this context, a number of reports have demonstrated the ability of diatom to report presence of nitrogen dioxide (NO 2 ) by decrease in their PL. In general, the adsorption of NO 2 onto DE silica shell results in static quenching of the surface-oxygen defects that give rise to the luminescence. [104] [105] [106] Lettieri et al. investigated the effect of temperature and NO 2 concentration on the PL intensity of DE silica shells and could detect up to 50 ppb of NO 2 . [107] The 3D structure of DE silica has been utilized by some studies to assemble plasmonic metal nanoparticles for surfaceenhanced Raman spectroscopy (SERS)-based sensing. [108] [109] [110] Adv. Healthcare Mater. 2018, 7, 1800552 Figure 15 . Data from the rat-tail amputation model among the diatomite (i.e., commercially purchased), diatom (i.e., diatoms obtained from lab culture), chitosan (1%)-coated diatoms (1-CS-diatom), gauze, and commercial Quikclot zeolite. a) Photograph of hemostatic effect by contacting with the wound. b) Clotting time. c) Blood loss. Data represent the mean ± S.D. (n = 6). Reproduced with permission. [95] Copyright 2016, ACS.
Kong et al. recently developed a method for in situ growth of plasmonic silver nanoparticles on DE silica, which were SERS active and could be used for SERS-based detection of air, water, and soil contaminants. [111] Others have self-assembled plasmonic nanoparticles onto DE silica surface for similar applications. DE silica shell has also been used for electrochemical sensing, where DE shell was used as filter to separate the target analyte from the sample. Lin et al. demonstrated such a system to detect cardiac biomarker at ultralow concentrations of ≈1 pg mL −1 with a linear range between 1 pg mL −1 and 1 µg mL −1 .
[112] Kabiri et al. used the DE silica for separation of food dye by packing the DE particles into a microfluidic channel, where detection was carried out by an optical probe. [113] The 3D porous structure of DE silica is recognized as a highly valuable template for growth of other functional microstructures with complex architectures that is not possible to fabricate by existing fabrication methods. Losic et al. used C. sp, Thalassiosira eccentric as template to generate positive and negative replicas of both metallic and polymeric structures and demonstrated their unique optical properties and capabilities to be sued for biosensing applications. [114] These diatom templatefabricated structures present valuable platforms we expect to be more explored in future for fabrication of low-cost biosensing devices for broad biomedical applications.
Conclusions
Diatoms with their unique 3D silica structures, created by genetically controlled self-assembled process under environment friendly conditions, provide blueprints for the development of new generation of biomaterials with properties that are not possible with synthetic porous silica materials. Featured by unique hierarchical porous structure with high surface area, tailorable surface modification together with high biocompatibility, chemical stability, specific optical, and photoluminescence properties, diatom frustules have been exploited as new and low-cost scaffold for broad range of biomedical applications. In this article, the most recent applications and concept of using diatoms as drug carriers and for biomedical applications were presented. The selected aspects of preparation of diatom carriers, their surface modifications, drug loading, and delivery capabilities to transport therapeutic molecules were in sustained and controllable way highlighted. The most recent development using converted diatoms silica into silicon degradable micro-and nanocarriers was demonstrated as a promising and inspiring strategy to further explore diatom silica material as a low-cost and valuable alternative to synthetic porous silicon for the preparation of new generation of nature-generated drug delivery systems. Indeed, there is considerable work to be done in investigating the biological response of diatom silica as a new pharmaceutical drug delivery carrier required for clinical applications. This also include needs for more studies to evaluate the efficacy and biocompatibility of diatom drug delivery system using in vivo conditions with animal and preclinical models. While the use of DE silica materials has been approved by the EPA, United States Department of Agriculture (USDA), and FDA to be used in food industry and agriculture, their use in pharmaceutical industry and medicine as additive and drug carriers does not have yet official regulatory approval. Considering their biological origin and proven biocompatibility and low cytotoxicity of DE silica or silicon DE by numerous in vitro and in vivo studies, this unique biomaterial has strong potential for biomedical applications, as highlighted in this review. Figure 16 . Chloroplast redistribution in living C. wailesii cell. Light micro scopy image of a single cell with a) evenly distributed chloroplasts. b) Chloroplast agglomeration after exposure to intense white irradiation. c) 3D reconstruction of a cell obtained by confocal laser scanning microscopy (CLSM) (Olympus Fluoview 1000): red emission comes from chloroplast autofluorescence, while green emission is due to silica frustule photoluminescence. Reproduced with permission. [101] Copyright 2014, Wiley-VCH.
